Caplin Point Laboratories Q4 Results

  • BSE: 524742
  • NSE: CAPLIPOINT
  • ISIN: INE475E01026
  • Sector: Biotechnology & Drugs
BSE
1,969.554.60 (0.23%)
Volume7.99 K
Updated: Mon 25 Nov, 2024 | 15:29:00
NSE
1,97713.25 (0.67%)
Volume65.86 K
Updated: Mon 25 Nov, 2024 | 15:29:51
Today: 1,945.00
2,005.00
52-Wk: 1,179.95
2,175.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Caplin Point Laboratories Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 453.22372.07-%389.28-%
    Selling/ General/ Admin Expenses Total 36.7734.54-%36.00-%
    Depreciation/ Amortization 16.4011.43-%11.13-%
    Other Operating Expenses Total 79.8564.26-%52.75-%
    Total Operating Expense 324.39274.13-%276.48-%
    Operating Income 128.8397.94-%112.80-%
    Net Income Before Taxes 146.03111.74-%124.05-%
    Net Income 121.5997.48-%102.11-%
    Diluted Normalized EPS 15.9012.75-%13.33-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts